ID

13683

Description

Maintenance Therapy: Lenalidomide Following Bendamustine and Rituximab Induction Therapy for Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01465230

Link

https://clinicaltrials.gov/show/NCT01465230

Keywords

  1. 2/28/16 2/28/16 -
Uploaded on

February 28, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
previous induction treatment with bendamustine and rituximab
Description

therapy induction ; bendamustine

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0857127
UMLS CUI [2]
C0525079
18 or more years of age
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
chronic lymphocytic leukemia
Description

chronic lymphocytic leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023434
ecog performance status less than or equal to 2
Description

ecog performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
absolute neutrophile count more than 1,000
Description

absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count more than 70,000
Description

platelet count

Data type

boolean

Alias
UMLS CUI [1]
C0032181
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
serious medical condition that would prevent treatment with lenalidomide
Description

comorbidity affecting treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0087111
evidence of tumor lysis syndrome
Description

tumor lysis syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0041364
any prior treatment with lenalidomide
Description

treatment lenalidomide

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1144149

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT01465230

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
therapy induction ; bendamustine
Item
previous induction treatment with bendamustine and rituximab
boolean
C0087111 (UMLS CUI [1,1])
C0857127 (UMLS CUI [1,2])
C0525079 (UMLS CUI [2])
age
Item
18 or more years of age
boolean
C0001779 (UMLS CUI [1])
chronic lymphocytic leukemia
Item
chronic lymphocytic leukemia
boolean
C0023434 (UMLS CUI [1])
ecog performance status
Item
ecog performance status less than or equal to 2
boolean
C1520224 (UMLS CUI [1])
absolute neutrophil count
Item
absolute neutrophile count more than 1,000
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count more than 70,000
boolean
C0032181 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
comorbidity affecting treatment
Item
serious medical condition that would prevent treatment with lenalidomide
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
tumor lysis syndrome
Item
evidence of tumor lysis syndrome
boolean
C0041364 (UMLS CUI [1])
treatment lenalidomide
Item
any prior treatment with lenalidomide
boolean
C0087111 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial